scispace - formally typeset
R

Robert Höllriegel

Researcher at Dresden University of Technology

Publications -  42
Citations -  2469

Robert Höllriegel is an academic researcher from Dresden University of Technology. The author has contributed to research in topics: Heart failure & Ejection fraction. The author has an hindex of 21, co-authored 41 publications receiving 1817 citations. Previous affiliations of Robert Höllriegel include Leipzig University.

Papers
More filters
Journal ArticleDOI

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Michel Azizi, +132 more
- 09 Jun 2018 - 
TL;DR: In this article, the authors investigated whether an alternative technology using endovascular ultrasound renal denervation reduces ambulatory blood pressure in patients with hypertension in the absence of antihypertensive medications.
Journal ArticleDOI

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.

Raban Jeger, +90 more
- 08 Sep 2018 - 
TL;DR: In small native coronary artery disease, DCB was non-inferior to DES regarding MACE up to 12 months, with similar event rates for both treatment groups.
Journal ArticleDOI

Exercise Training in Patients With Advanced Chronic Heart Failure (NYHA IIIb) Promotes Restoration of Peripheral Vasomotor Function, Induction of Endogenous Regeneration, and Improvement of Left Ventricular Function

TL;DR: Twelve weeks of ET in patients with advanced CHF is associated with augmented regenerative capacity of CPCs, enhanced flow-mediated dilation suggestive of improvement in endothelial function, skeletal muscle neovascularization, and improved LV function.
Journal ArticleDOI

Exercise training leads to a reduction of elevated myostatin levels in patients with chronic heart failure

TL;DR: The observed effects of a significant reduction of myostatin in skeletal muscle after 12 weeks of exercise training demonstrate the reversibility of molecular changes that might be able to halt the devastating process of muscle wasting in chronic heart failure.